Exercise decreases plasma antioxidant capacity and increases urinary isoprostanes of IPF patients

Respiratory Medicine

Volumn 104, Issue 12, 2010, Pages 1919-1928

  Jackson, R ^a,b   Ramos, C ^a   Gupta, C ^a   Gomez Marin, O ^a,b  

^a Miami VAHS   (United States)

^b UNIVERSITY OF MIAMI   (United States)

Author keywords

Exercise; Idiopathic pulmonary fibrosis; Oxidant stress

Indexed keywords

AMINO TERMINAL PRO BRAIN NATRIURETIC PEPTIDE; HYDROGEN PEROXIDE; ISOPROSTANE DERIVATIVE; NITRITE; REACTIVE OXYGEN METABOLITE; WATER;

ADULT; AGED; ANTIOXIDANT ACTIVITY; ARTICLE; CLINICAL ARTICLE; CREATININE URINE LEVEL; DYSPNEA; EXERCISE TEST; FEMALE; FIBROSING ALVEOLITIS; HUMAN; LACTATE BLOOD LEVEL; LUNG ARTERY PRESSURE; MALE; OUTCOME ASSESSMENT; OXIDATIVE STRESS; PRIORITY JOURNAL; PULMONARY HYPERTENSION; URINALYSIS; WILCOXON SIGNED RANKS TEST;

AGED; BIOLOGICAL MARKERS; EXERCISE THERAPY; FEMALE; HUMANS; HYDROGEN PEROXIDE; IDIOPATHIC PULMONARY FIBROSIS; ISOPROSTANES; MALE; NATRIURETIC PEPTIDE, BRAIN; OXIDATIVE STRESS; PEPTIDE FRAGMENTS; PREDICTIVE VALUE OF TESTS;

EID: 78650034488     PISSN: 09546111     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.rmed.2010.07.021     Document Type: Article

References (46)

1. American thoracic society/European respiratory society international multidisciplinary consensus classification of the idiopathic interstitial pneumonias Am J Respir Crit Care Med 165 2002 277 304
2. A. Wells, and N. Hirani Interstitial lung disease guideline: the british thoracic society in collaboration with the thoracic society of Australia and New Zealand and the Irish thoracic society Thorax 63 2008 v1 v58
3. V. Kinnula Redox imbalance and lung fibrosis Antioxid Redox Signal 10 2008 249 252
4. I. Rahman, E. Skwarska, M. Henry, M. Davis, C. O'Connor, and M. FitzGerald Systemic and pulmonary oxidative stress in idiopathic pulmonary fibrosis Free Radic Biol Med 27 1999 60 68
5. Z. Yildrim, M. Kotuk, M. Iraz, I. Kuku, and R. Ulu Attenuation of bleomycin-induced lung fibrosis by oral sulfhydryl containing antioxidants in rats: erdosteine and N-acetylcysteine Pulm Pharmacol Ther 18 2005 367 373
6. A. Serrano-Mollar, D. Closa, N. Prats, and S. Blesa In vivo antioxidant treatment protects against bleomycin-induced lung damage in rats Br J Pharmacol 138 2003 1037 1048
7. R. Bowler, M. Nicks, K. Warnick, and J. Crapo Role of extracelluar superoxide dismutase in bleomycin-induced pulmonary fibrosis Am J Physiol Lung Cell Mol Physiol 282 2002 L719 L726
8. B. Day Antioxidants as potential therapeutics for lung fibrosis Antioxid Redox Signal 10 2008 355 370
9. C. Hye-Young, S. Reddy, M. Yamamoto, and S. Kleeberger The transcription factor Nrf2 protects against pulmonary fibrosis FASEB J 18 2004 1258 1260
10. M. Demedts, J. Behr, R. Buhl, U. Constable, R. Dekhuijzen, and H. Jansen High-dose acetylcysteine in idiopathic pulmonary fibrosis N Engl J Med 353 2005 2229 2242
11. V. Felton, Z. Borok, and B. Willis N-acetylcysteine inhibits alveolar epithelial-mesenchymal transition Am J Physiol Lung Cell Molec Physiol 297 2009 L805 L812
12. A. Cantin, S. North, G. Fells, R. Hubbard, and R. Crystal Oxidant-mediated epithelial cell injury in idiopathic pulmonary fibrosis J Clin Invest 79 1987 1665 1673
13. A. Cantin, R. Hubbard, and R. Crystal Glutathione deficiency in the epithelial lining fluid of lower respiratory tract in idiopathic pulmonary fibrosis Am Rev Respir Dis 139 1988 370 372
14. J. Behr, K. Maier, B. Degenkob, F. Krombach, and C. Vogelmeier Antioxidative and clinical effects of high-dose N-acetylcysteine in fibrosing alveolitis Am J Respir Crit Care Med 156 1997 1897 1901
15. X. Fu, S. Kassim, W. Parks, and J. Heinecke Hypochlorous acid generated by myeloperoxidase modifies adjacent tryptophan and glycine residues in the catalytic domain of matrix metalloproteinase-7 (matrilysin). An oxidative mechanism for restraining proteolytic activity during inflammation J Biol Chem 278 2003 28403 28409
16. V. Kinnula, C. Fattman, R. Tan, and T. Oury Oxidative stress in pulmonary fibrosis. A possible role for redox modulatory therapy Am J Respir Crit Care Med 172 2005 417 422
17. R. Jackson, C. Ramos, M. Glassberg, P. Bejarano, and O. Gomez-Marin Vasodilator therapy and exercise tolerance in idiopathic pulmonary fibrosis: A randomized, placebo controlled trial of sildenafil Lung 188 2010 115 123
18. H. Leuchte, C. Neurohr, R. Baumgartner, M. Holzapfel, W. Giehrl, and M. Vogeser Brain natriuretic peptide and exercise capacity in lung fibrosis and pulmonary hypertension Am J Resp Crit Care Med 170 2004 360 365 (Pubitemid 39214607)
19. R. Elin, and W. Winter Laboratory and clinical aspects of b-type natriuretic peptides Arch Pathol Lab Med 128 2004 697 699
20. L. Lundholm, E. Mohme-Lundholm, and N. Vamos Lactic acid assay with L(+) lactic acid dehydrogenase from rabbit muscle Acta Physiol Scand 58 1963 243 249
21. 2t-isoprostane in human urine and plasma Clin Chem 53 2007 489 497
22. D. Tsikas Analysis of nitrite and nitrate in biological fluids by assays based on the Griess reaction: appraisal of the Griess reaction in the L-arginine/nitric oxide area of research J Chromatogr 851 2007 51 70
23. J. de Andrade, J. Crow, L. Viera, C. Alexander, K. Young, and D. McGiffin Protein nitration, metabolites of reactive nitrogen species, and inflammation in lung allografts Am J Respir Crit Care Med 161 2000 2035 2042
24. B. Frei, R. Stocker, and B. Ames Antioxidant defenses and lipid peroxidation in human blood plasma Proc Natl Acad Sci 85 1988 9748 9752
25. L. Long, P. Evan, and B. Halliwell Hydrogen peroxide in human urine: implications for antioxidant defense and redox regulation Biochem Biophys Res Commun 262 1999 605 609
26. 2-Isoprostanes in human health and diseases: from molecular mechanisms to clinical implications Antioxid Redox Signal 10 2008 1405 1434
27. A. Becker, S. Uckert, D. Tsikas, H. Noack, C. Stief, and J. Frolich Determination of nitric oxide metabolites by means of the Griess assay and gas chromatography-mass spectrometry in the cavernous and systemic blood of healthy males and patients with erectile dysfunction during different functional conditions of the penis Urol Res 28 2000 364 369
28. P. Markart, T. Luboeinski, M. Korfei, R. Schmidt, M. Wygrecka, and P. Mahavida Alveolar oxidative stress is associated with elevated levels of nonenzymatic low-molecular weight antioxidants in patients with different forms of chronic fibrosing interstitial lung disease Antioxid Redox Signal 11 2009 227 240
29. D. Saleh, P. Barnes, and A. Giaid Increased production of the potent oxidant peroxynitrite in the lungs of patients with idiopathic pulmonary fibrosis Am J Respir Crit Care Med 155 1997 1763 1769
30. C. Koechlin, F. Maltais, D. Saey, A. Michaud, P. LeBlanc, and M. Hayot Hypoxemia enhances peripheral muscle oxidative stress in chronic obstructive pulmonary disease Thorax 60 2005 834 841
31. R. Richardson, S. Duteil, D. Wary, D. Wray, J. Hoff, and P. Carlier Human skeletal muscle intracellular oxygenation: the impact of ambient oxygen availability J Physiol 571 2006 415 424
32. A. Meyer, R. Buhl, and H. Magnussen The effect of oral N-acetylcysteine on lung glutathione levels in idiopathic pulmonary fibrosis Eur Respir J 7 1994 431 436
33. A. Meyer, R. Buhl, S. Kampf, and H. Magnussen Intravenous N-acetylcysteine and lung glutathione of patients with pulmonary fibrosis and normals Am J Respir Crit Care Med 152 1995 1055 1060
34. K. Katsoulis, T. Kontakiotis, I. Leonardopoulos, A. Kotsovili, I. Legakis, and D. Patakas Serum total antioxidant status in severe exacerbation of asthma: correlation with the severity of the disease J Asthma 40 2003 847 854
35. A. Nadeem, H. Raj, and S. Chhabra Increased oxidative stress and altered levels of antioxidants in chronic obstructive pulmonary disease Inflammation 29 2005 23 32
36. H. Cowley, P. Bacon, J. Pamela, H. Goode, N. Webster, and G. Jones Plasma antioxidant potential in severe sepsis: a comparison of survivors and nonsurvivors Crit Care Med 24 1996 1179 1183
37. D. Banerfjee, U. Madhusoodanan, S. Nayak, and J. Jacob Urinary hydrogen peroxide: a probable marker of oxidative stress in malignancy Clin Chim Acta 334 2009 205 209
38. S. Baldus, J. Eiserich, R. Jackson, C. Alexander, and B. Freeman Spatial mapping of nitrotyrosine in vascular and pulmonary inflammatory diseases reveals a pivotal role for myeloperoxidase as a catalyst for tyrosine nitration in vivo Free Radic Biol Med 33 2002 1010 1019
39. P. Cerretelli, and M. Samaja Acid-base balance at exercise in normoxia and in chronic hypoxia. Revisiting the "lactate paradox." Eur J Appl Physiol 90 2003 431 448
40. J. Rush, J. Turk, and M. Laughlin Exercise training regulates SOD-1 and oxidative stress in porcine aortic endothelium Am J Physiol Circ Physiol 284 2003 H1378 H1387
41. C. Sen Oxidants and antioxidants in exercise J Appl Phys 79 1995 675 686
42. A. McArdle, J. van der Meulen, G. Close, D. Pattwell, H. Van Remmen, and T. Huang Role of mitochondrial superoxide dismutase in contraction-induced generation of reactive oxygen species in skeletal muscle extracellular space Am J Physiol, Cell Physiol 286 2004 C1152 C1158
43. 2 therapy J Appl Phys 81 1996 2199 2202
44. L. Heunks, J. Viña, C. Van Herwaaden, T. Folgering, A. Gimeno, and R. Dekhuijzen Xanthine oxidase is involved in exercise-induced oxidative stress in chronic obstructive pulmonary disease Am J Phys 277 1999 R1697 R1704 (Regulatory Integrative Comp Physiol 46)
45. F. McArdle, S. Spiers, H. Aldemir, A. Vasilaki, A. Beaver, and L. Iwanejko Preconditioning of skeletal muscle against contraction-induced damage: the role of adaptations to oxidants in mice J Physiol 561 2004 233 244
46. E. Mercken, G. Hageman, A. Schols, M. Akkermans, A. Bast, and E. Wouters Rehabilitation decreases exercise-induced oxidative stress in chronic obstructive pulmonary disease Am J Respir Crit Care Med 172 2005 994 1001